Results 141 to 150 of about 3,798 (162)

Pharmacological Management for Prevention and Treatment of Posthepatectomy Liver Failure.

open access: yesDig Surg
Gerritsen A   +6 more
europepmc   +1 more source

Terlipressin: Current and emerging indications in chronic liver disease [PDF]

open access: yesJournal of Gastroenterology and Hepatology (Australia), 2018
Terlipressin is an analogue of vasopressin that has potent vasoactive properties and has been available for use in most countries for nearly two decades.
Paul J Gow, Timothy Papaluca
exaly   +2 more sources

Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis

open access: yesJournal of Gastroenterology and Hepatology (Australia), 2005
BACKGROUND AND AIM: Terlipressin and somatostatin are the most preferable agents for the control of variceal bleeding in cirrhotic patients. The present study evaluated the hemodynamic effects of somatostatin, terlipressin and somatostatin plus ...
Epameinondas V Tsianos   +1 more
exaly   +1 more source

Effect of terlipressin on blood volume distribution in patients with cirrhosis

open access: yesScandinavian Journal of Gastroenterology, 2004
Udgivelsesdato: 2004-MayBACKGROUND: Patients with cirrhosis and portal hypertension have an altered blood volume distribution and a hyperdynamic systemic circulation.
Søren Møller   +2 more
exaly   +1 more source

Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis

Journal of Gastroenterology and Hepatology (Australia), 2009
Choitsu Sakamoto   +2 more
exaly  

Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis

Journal of Hepatology, 2014
Carlo Alessandria   +2 more
exaly  

Home - About - Disclaimer - Privacy